Bacterial keratitis: Difference between revisions

(Text replacement - "4 mg" to "4mg")
(Text replacement - "0 mg" to "0mg")
Line 41: Line 41:
*Broad spectrum topical antibiotics; 1 drop q1 hr
*Broad spectrum topical antibiotics; 1 drop q1 hr
**Tobramycin 14mg/ml
**Tobramycin 14mg/ml
**Alternate with fortified cefazolin 50 mg/ml
**Alternate with fortified cefazolin 50mg/ml
*Smaller corneal ulcers may be treated with moxifloxacin or gatifloxacin ophthalmic
*Smaller corneal ulcers may be treated with moxifloxacin or gatifloxacin ophthalmic



Revision as of 12:16, 20 July 2016

Background

  • Rapidly progressing, with corneal destruction as fast as within 24 hrs
  • Corneal perforation is most sight threatening complication
  • Strep, staph, pseudomonas, enterobacteriaceae
  • Risk factors
    • Contact lens use
    • Corneal surgery, trauma
    • Chronic dry eye
    • Recent corneal disease (viral, fungal keratitis)
    • Immune deficiency, topical steroids

Clinical Features

  • Blurred vision
  • Severe pain and photophobia
  • Perilimbic injection
  • Normal pupil size
  • Eyelid edema
  • Mucopurulent exudate
  • Posterior synechiae (iris adheres to cornea)

Differential Diagnosis


Diagnosis

  • Topical anesthesia with proparacaine, as opposed to tetracaine which has bacteriostatic effects, limiting culture results
  • Culture and gram stain of corneal ulcer edges, eyelids, conjunctiva, contact lenses
  • Ultrasound to assess for signs of endophthalmitis and other pathologies

Management

  • Broad spectrum topical antibiotics; 1 drop q1 hr
    • Tobramycin 14mg/ml
    • Alternate with fortified cefazolin 50mg/ml
  • Smaller corneal ulcers may be treated with moxifloxacin or gatifloxacin ophthalmic

Disposition

  • Ophtho consult for possible perforation risk
  • Eye patch in the interim

References